Effect of Cold Application on Patient's Pain and Vital Signs During Chest Tube Removal.

March 13, 2023 updated by: Gonca Karayagiz Muslu, Muğla Sıtkı Koçman University

Investigation of the Effect of Cold Application on Patient's Pain and Vital Signs During Chest Tube Removal.

In this study, the effect of cold application used during and after chest tube removal on pain and vital signs in infants and children in the 0-3 age group will be examined.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

Purpose of the research:In this study, the effect of cold application used during and after breast tube removal on pain and life signs in infants and children aged 0-3 years will be examined.

Hypotheses:

H1: children who have cold application around the tube 15 minutes before chest tube removal have low pain scores during chest tube removal compared to other groups.

H2: Children whose skin temperature is lowered below 13.60 C before breast tube removal have lower pain scores compared to other groups.

H3: The cold application technique in the group of children affects the crying time after the procedure.

H4: The cold application technique in the group of children affects the signs of life before and after the procedure.

The research is a study in randomized controlled, prospective and cross-sectional design.

The data of the study will be collected using the Patient Identification Information Form, FLACC Pain Scale, Life Signs Follow-up Form.

Study Type

Interventional

Enrollment (Anticipated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Muğla
      • Fethiye, Muğla, Turkey, 48300
        • Gonca Muslu

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 month to 3 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Between the ages of 0-3 years old,
  • The chest tube is located for at least 24 hours,
  • Without Mechanical ventilation support,
  • Does not have any allergies to the drug
  • Stable from the cardiovascular side

Exclusion Criteria:

  • Children with any neurological diseases,
  • Children with anynephrological
  • Children with any respiratory diseases

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: cold application Group
a cold gel pack will be wrapped in gauze and placed directly on the skin in an area with a radius of about 5 cm to cover the chest tube. The cold gel package will remain on the skin surface for about 20 minutes.
Oral paracetamol 10 mg/kg, which is administered as standard 60 minutes before the procedure, will be given to patients who have decided to remove the chest tube by the physician and comply with the limitations of the study. After that, initial pain severity and vital signs of the patient will be recorded using FLACC 15 minutes before the start of the chest tube removal process (1.MEASURE). After this measurement, the cold gel package will be wrapped in gauze and placed directly on the skin, covering the area around the chest tube with a radius of about 5 cm. The cold gel package will remain on the skin surface for about 20 minutes. After 15 minutes, the cold package will be removed and the chest tube will be removed by the doctor.
Experimental: Cold Application Group with Thermometer
10 of cold application. After a minute, the skin temperature will be measured with an infrared thermometer if the temperature has dropped below 13.6 o C, the procedure will be terminated. If the skin temperature has not decreased below 13.6 0 C, the application will be continued, the application will be terminated when the temperature drops below the specified temperature.
After measurements, the cold gel package, which rotates with one end open and forms a circle, will be wrapped in gauze and placed directly on the skin in a radius of about 5 cm, covering around the chest tube. 10 of the app. After the minute, the skin temperature will be measured with an infrared thermometer if the heat falls below 13.6 o C, the process will be terminated. If the skin temperature does not fall below 13.6 0 C, the application will continue, the application will be terminated when the heat falls below the specified temperature. After the cold package is removed, the chest tube will be removed by the doctor.
No Intervention: control Group
standard pain procedure.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain assessed by FLACC
Time Frame: before cold application,
the intensity of pain at the chest tube
before cold application,
Pain assessed by FLACC
Time Frame: immediately after chest tube removal ,
the intensity of pain at the chest tube
immediately after chest tube removal ,
Pain assessed by FLACC
Time Frame: 15 minutes after chest tube removal
the intensity of pain at the chest tube
15 minutes after chest tube removal
vital signs
Time Frame: before cold application,
pulse, oxygen saturation, temperature, respiratory rate.
before cold application,
vital signs
Time Frame: immediately after chest tube removal ,
pulse, oxygen saturation, temperature, respiratory rate.
immediately after chest tube removal ,
vital signs
Time Frame: 15 minutes after chest tube removal
pulse, oxygen saturation, temperature, respiratory rate.
15 minutes after chest tube removal

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
crying time
Time Frame: immediately after chest tube removal ,
crying time because of pain (SECOND)
immediately after chest tube removal ,
crying time
Time Frame: 15 minutes after chest tube removal
crying time because of pain. (SECOND)
15 minutes after chest tube removal

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

October 15, 2023

Primary Completion (Anticipated)

October 15, 2024

Study Completion (Anticipated)

October 15, 2024

Study Registration Dates

First Submitted

September 15, 2021

First Submitted That Met QC Criteria

September 15, 2021

First Posted (Actual)

September 16, 2021

Study Record Updates

Last Update Posted (Actual)

March 14, 2023

Last Update Submitted That Met QC Criteria

March 13, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 272

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chest Tube Removal

Clinical Trials on cold application

3
Subscribe